How is generative AI being utilized in drug discovery to improve processes and secure higher-quality drugs?
In a year where both the Chemistry and Physics Nobel Prizes have been awarded for foundational contributions to artificial intelligence (AI), it is the perfect time to explore how AI and robotics are reshaping drug discovery. This field stands out as a key area for AI application, free from many of the ethical or regulatory challenges faced in other domains. As new technologies emerge, the exploration of chemical space for novel therapies is accelerating. By streamlining molecular design, automating synthesis and enhancing the overall quality and speed of discovery, AI is opening the door to the next frontier in drug discovery.
Please follow this link to access this editorial piece.
